Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
28 déc. 2022 16h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual...
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day
15 déc. 2022 16h00 HE
|
Akoya Biosciences, Inc.
New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to improve patient outcomes Ready-to-use panels,...
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
07 nov. 2022 16h05 HE
|
Akoya Biosciences, Inc.
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and...
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
07 nov. 2022 16h05 HE
|
Akoya Biosciences, Inc.
Q3 2022 revenue $18.9 million, 40% y/y growthRaising FY 2022 revenue guidance range to $73-75 million MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA)...
Akoya to Participate at Three Upcoming Investor Conferences
03 nov. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming...
Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022
11 oct. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya to Participate at Four Upcoming Investor Conferences
31 août 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in four upcoming...
Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
08 août 2022 16h05 HE
|
Akoya Biosciences, Inc.
Q2 2022 revenue $17.9 million, 37% y/y growthRaising FY 2022 revenue guidance range to $71-74 million MARLBOROUGH, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA)...
Akoya to Participate at Two Upcoming Investor Conferences
27 juil. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in two upcoming...
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022
12 juil. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...